SAVUTH KEM: Open Payments
NPI 1225264419 · LOS BANOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,836 in 107 payments from 14 companies in 2025. Trend: 2023 $663 · 2024 $922 · 2025 $1,836
Food & beverage: $1,836
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 27 | $359 |
| AstraZeneca Pharmaceuticals LP | 4 | $279 |
| Amgen Inc. | 20 | $221 |
| Novo Nordisk Inc | 9 | $204 |
| PFIZER INC. | 12 | $158 |
| GlaxoSmithKline, LLC. | 16 | $153 |
| Corcept Therapeutics | 2 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $115 |
| Astellas Pharma US Inc | 4 | $76 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
Products named: JARDIANCE, AIRSUPRA, OTEZLA, Korlym, NURTEC ODT, Wegovy, TRELEGY ELLIPTA, Kerendia.
Industry payments across CA — which companies pay providers there.
